Maria Flavia Guinazu is a retired professor of biophysics from the Department of Biotechnics at the Hungarian University of Agriculture and Life Sciences in Hungary. He is the founder of Oncotherm Inc., a company based in Hungary and Germany, dedicated to advancing oncothermia technology in cancer treatment.

Her work in translational, transformative medicine aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary approach for CNS disease treatment and prevention. Deep knowledge of drug production process including CD plan, biomarkers, and pharmacovigilance.

Since 2015, she is working on digital health as both Researcher and Medical Advisor developing platforms to predict adherence, early disease diagnosis and interventions in: melanomas, VIH/SIDA; neurology and mental health